Comparative evaluation of intermountain risk score with Mehran risk score for risk estimation of contrast-induced nephropathy and short-term mortality in ST-segment elevation myocardial infarction patients

Basit Öğe Kaydı
dc.authorid0000-0001-8923-8709
dc.authorid0000-0002-4297-1820
dc.contributor.authorToprak, Kenan
dc.contributor.authorKaplangöray, Mustafa
dc.contributor.authorMemioğlu, Tolga
dc.contributor.authorİnanir, Mehmet
dc.contributor.authorErmiş, Mehmet Fatih
dc.contributor.authorToprak, İbrahim Halil
dc.contributor.authorAcar, Osman
dc.date.accessioned2024-09-25T19:57:29Z
dc.date.available2024-09-25T19:57:29Z
dc.date.issued2023
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractContrast-induced nephropathy (CIN) has become one of the most important causes of in-hospital acute renal failure with the increasing use of contrast-mediated imaging tools. This significantly increases the morbidity and mortality of the affected subjects and causes a financial burden on the health system. In this context, prediction of CIN is important and some risk scores have been developed to predict CIN. The most frequently used and popular among these is the Mehran Score (MS), which is based on a number of hemodynamic and metabolic parameters. The Intermountain Risk Score (IMRS) is a recently developed risk score that highly predicts short-term mortality based on common laboratory parameters, and many parameters of this risk score have been found to be closely associated with CIN. In this context, we aimed to compare MS and IMRS in terms of CIN and short-term mortality estimation. The study included 931 patients who underwent percutaneous coronary intervention. CIN developed in 21.5% of patients. Both MS and IMRS independently predicted CIN. In receiver operating characteristic analysis, IMRS was found to be non-inferior to MS in predicting CIN and IMRS was superior to MS in predicting short-term mortality. IMRS and MS were independently associated with short-term mortality.en_US
dc.identifier.doi10.1177/00033197231201931
dc.identifier.endpage12
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.pmid37672723en_US
dc.identifier.scopus2-s2.0-85170539215en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.1177/00033197231201931
dc.identifier.urihttps://hdl.handle.net/20.500.12491/13450
dc.identifier.wosWOS:001060069700001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorMemioğlu, Tolga
dc.institutionauthorİnanir, Mehmet
dc.institutionauthorid0000-0002-3183-5815
dc.institutionauthorid0000-0003-1784-3584
dc.language.isoenen_US
dc.publisherSage Publications Incen_US
dc.relation.ispartofAngiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzYK_20240925en_US
dc.subjectContrast-Induced Nephropathyen_US
dc.subjectIntermountain Risk Scoreen_US
dc.subjectMehran Risk Scoreen_US
dc.subjectST-Elevation Myocardial Infarctionen_US
dc.subjectShort-Term Mortalityen_US
dc.titleComparative evaluation of intermountain risk score with Mehran risk score for risk estimation of contrast-induced nephropathy and short-term mortality in ST-segment elevation myocardial infarction patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
kenan-toprak.pdf
Boyut:
1.04 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu